Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial

Radiotherapy and Oncology

Volumn 100, Issue 1, 2011, Pages 56-61

  Bourhis, Jean ^a   Lapeyre, Michel ^b,c   Tortochaux, Jacques ^c   Lusinchi, Antoine ^a   Etessami, Atoussa ^a   Ducourtieux, Murielle ^a   Geoffrois, Lionel ^b   Domenge, Christian ^a   Verrelle, Pierre ^c   Wibault, Pierre ^a   Janot, Franois ^a   Temam, Stephane ^a   Blanchard, Pierre ^a   Tao, Yun G ^a   Auperin, Anne ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c CENTRE JEAN PERRIN   (France)

Author keywords

Chemotherapy; Dose intensity; Head and neck cancer; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; EVENT FREE SURVIVAL; FEMALE; FIBROSIS; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HOSPITALIZATION; HUMAN; HYPOPHARYNX CARCINOMA; KIDNEY DISEASE; LARYNX DISORDER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MUCOSAL DISEASE; MULTIPLE CYCLE TREATMENT; NECK FIBROSIS; NEPHROTOXICITY; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 80051781309     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.006     Document Type: Article

References (26)

1. J.P. Pignon, J. Bourhis, C. Domenge, L. Designe On behalf of the MACH-NC collaborative group Meta-analysis of chemotherapy in head and neck squamous cell carcinoma Lancet 355 2000 949 955
2. J.P. Pignon, A. le Maitre, E. Maillard, and J. Bourhis Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
3. Y. Tao, and K. Rezaï Brain A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma Radiother Oncol 98 2011 42 47
4. V. Loimu, J. Collan, and L. Vaalavirta Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin Radiother Oncol 98 2011 34 37
5. K.S. Choe, J.K. Salama, and K.M. Stenson Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer Radiother Oncol 97 2010 318 321
6. R. Hitt, A. Lopez-Pousa, and J. Martinez-Trufero Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 23 2005 8636 8645 (Pubitemid 46211506)
7. A. Paccagnella, A. Orlando, and C. Marchiori Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo J Natl Cancer Inst 86 1994 265 272 (Pubitemid 24057404)
8. D.M. Brizel, M.E. Albers, and S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804 (Pubitemid 28277960)
9. V. Budach, M. Stuschke, and W. Budach Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial J Clin Oncol 23 2005 1125 1135 (Pubitemid 46202268)
10. R.J. Bensadoun, K. Benezery, and O. Dassonville French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC) Int J Radiat Oncol Biol Phys 64 2006 983 994
11. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086 (Pubitemid 30019568)
12. F. Denis, P. Garaud, and E. Bardet Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemoradiotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems Int J Radiat Oncol Biol Phys 55 2003 93 98 (Pubitemid 36020347)
13. L. Walsh, C. Gillham, and M. Dunne Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC) Radiother Oncol 98 2011 38 41
14. J.C. Horiot, R. LeFur, and T. N' Guyen Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231 241 (Pubitemid 23000765)
15. W. Dobrowsky, E. Dobrowsky, and J. Naudi Conventional versus accelerated in advanced head and neck cancer Br J Cancer 74 1996 279 281
16. M. Saunders, S. Dische, and A. Barrett Randomized multicentre trial of CHART vs conventional radiotherapy in head and neck and non small cell lung cancer: an interim report Br J Cancer 73 1996 1455 1462 (Pubitemid 26235366)
17. K. Fu, J. Cooper, and V. Marcial Evolution of the radiation therapy oncology group clinical trials for head and neck cancer Int J Radiat Oncol Biol Phys 35 1996 425 438 (Pubitemid 26242889)
18. J. Overgaard, H.S. Hansen, and L. Specht Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 2003 933 940 (Pubitemid 37159288)
19. J. Bourhis, M. Lapeyre, and J. Tortochaux Phase III randomized trial of very accelerated compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial J Clin Oncol 24 2006 2873 2878 (Pubitemid 46630588)
20. J. Bourhis, J. Overgaard, and H. Audry Hyperfractionated of accelerated radiotherapy in head and neck cancer: a meta-analysis Lancet 368 2006 843 854 (Pubitemid 44292807)
21. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
22. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
23. J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704 (Pubitemid 350005151)
24. M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715 (Pubitemid 350005152)
25. Y. Pointreau, P. Garaud, and S. Chapet Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 2009 498 506
26. H. Suit, T. De Laney, S. Goldberg, H. Paganetti, and B. Clasie Proton vs carbon ion beams in the definitive radiation treatment of cancer patients Radiother Oncol 95 2010 3 22